ACE inhibitors in heart failure: effect on mode of death.

@article{Kubler1997ACEII,
  title={ACE inhibitors in heart failure: effect on mode of death.},
  author={Wolfgang Kübler},
  journal={European heart journal},
  year={1997},
  volume={18 1},
  pages={
          3-4
        }
}
  • W. Kübler
  • Published 1997
  • Medicine, Biology
  • European heart journal
The treatment of heart failure with ACE inhibitors, especially following acute myocardial infarction, is now well established. Several excellent studies have convincingly demonstrated increased survival and reduced morbidity necessitating fewer hospital admissions. In the Acute Infarction Ramipril Efficacy (AIRE) study 5 mg b.d. of the ACE inhibitor ramipril were given to patients with some clinical evidence of heart failure, even if transient, 3-10 days after myocardial infarction. After an… 
Most Heart Failure Patients Die from Pump Failure: Implications for Therapy
TLDR
Patients with optimally treated patients are at greater risk for the consequences of pump failure, and a priority for current research should be therapies that reduce pump failure death and hospitalization for more cost-effective management of the disease.
Conceptos actuales sobre la muerte súbita
La muerte subita se define como aquella que ocurre antes de una hora de la aparicion de los sintomas. Es una condicion grave que en diversos paises supone un problema de salud publica y que en Mexico

References

SHOWING 1-6 OF 6 REFERENCES
Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.
TLDR
Ramipril reduces mortality and progression to resistant heart failure among patients with evidence of heart failure early after myocardial infarction and appears to be a major factor contributing to the reduction in mortality both by reducing circulatory failure and by reducing sudden death.
Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure
TLDR
Total mortality and hospitalization for congestive heart failure are significantly reduced by ACE inhibitors with consistent effects in a broad range of patients.
Untersuchungen zum Mineralstoffwechsel und zum Verhalten neurohormonaler Systeme bei Patienten mit kardiovaskuliiren Erkrankungen
  • Habilitationsschnft zur Erlangung der venia legendi einer hohen Medizinischen Fakukltat der Ruprecht-Karls-Universitat
  • 1982
Yusuf S Overview of randomized trials of angiotensin - converting enzyme inhibitors on mortality and morbidity in patients with heart failure
  • JAMA
  • 1995